Stocks Health care PSTV
NASDAQ · Health careCerenome, Inc. (PSTV)
Cerenome, Inc. brought in $4.2M of revenue over the twelve months to June 30, 2026, down 21.0% from a year earlier. It posted a net loss of $26.1M. In fiscal 2025 capital spending exceeded operating cash flow by $20.8M. At June 30, 2026 it held $2.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch PSTV in 60 secondsWhat Cerenome, Inc. does
Cerenome, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PSTV.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $5.2M | -$22.4M | -$0.29 | -$20.8M |
| 2024 | $5.8M | -$13M | -$2.34 | -$10.7M |
| 2023 | $4.9M | -$13.3M | -$4.24 | -$13M |
| 2022 | n/a | -$20.3M | -$11.58 | n/a |
| 2021 | n/a | -$13.4M | -$16.69 | n/a |
| 2020 | n/a | -$8.2M | -$27.97 | n/a |
Full financial statements: income, balance sheet and cash flow
Where PSTV ranks in Health care
Latest SEC filings
What Cerenome, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 10, 2026
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 70% to $411K versus the same quarter last year; diluted EPS -$1.31 versus -$0.16.
- August 14, 2026
- August 4, 2026
- June 18, 2026
- June 5, 2026
- June 5, 2026
- June 2, 2026
- May 15, 2026
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 2.9% to $1M versus the same quarter last year; diluted EPS -$1.05 versus -$29.86.
Insider trades
What the people running Cerenome, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 11 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 1, 2026 | Clowes HowardDirector | Exercised options | 922 | - |
| July 1, 2026 | Hedrick Marc HChief Executive Officer, Director | Exercised options | 6,387 | - |
| July 1, 2026 | Hedrick Marc HChief Executive Officer, Director | Exercised options | 8,066 | - |
| July 1, 2026 | Hedrick Marc HChief Executive Officer, Director | Exercised options | 1,986 | - |
| July 1, 2026 | van Es-Johansson AnDirector | Exercised options | 922 | - |
| July 1, 2026 | Guse KyleDirector | Exercised options | 922 | - |
| July 1, 2026 | Hawkins Richard JDirector | Exercised options | 922 | - |
| July 1, 2026 | Sims Andrew John Hugh MacIntyreChief Financial Officer | Exercised options | 1,533 | - |
| July 1, 2026 | Sims Andrew John Hugh MacIntyreChief Financial Officer | Exercised options | 1,165 | - |
| July 1, 2026 | Sims Andrew John Hugh MacIntyreChief Financial Officer | Exercised options | 287 | - |
| July 1, 2026 | Andrews Ronald AsburyDirector | Exercised options | 922 | - |
Who owns PSTV
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Highbridge Capital Management, LLC13G, passive | 7.1% | May 15, 2026 |
Largest institutional holders
Insiders
7 insiders reported holding 60,700 shares in total, about $234.9K at the last price.
| Holder | Shares |
|---|---|
| Hedrick Marc HChief Executive Officer, Director | 44,483 |
| Sims Andrew John Hugh MacIntyreChief Financial Officer | 9,941 |
| Clowes HowardDirector | 1,981 |
| Hawkins Richard JDirector | 1,529 |
| Guse KyleDirector | 922 |
| Andrews Ronald AsburyDirector | 922 |
| van Es-Johansson AnDirector | 922 |
Questions about PSTV
What does Cerenome, Inc. do?
Cerenome, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PSTV.
Is Cerenome, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $26.1M on revenue of $4.2M.
How much revenue does Cerenome, Inc. make?
Over the twelve months to June 30, 2026 Cerenome, Inc. reported revenue of $4.2M. That is 21.0% less than a year earlier.
When did Cerenome, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 10, 2026.
Similar companies
Compare PSTV with
Follow PSTV
Get an email when Cerenome, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PSTV: get an email when it filesWhere the numbers come from
Financial figures are the values Cerenome, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.